样式: 排序: IF: - GO 导出 标记为已读
-
Preliminary results from a multicenter, randomized trial using fecal microbial transplantation to induce remission in patients with mild to moderate Crohn's disease. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-11-12 Dina Kao,Karen Wong,Humberto Jijon,Paul Moayyedi,Rose Franz,Chelsea McDougall,Naomi Hotte,Remo Panaccione,Eric Semlacher,Karen I Kroeker,Farhad Peerani,Karen V MacDonald,Huiping Xu,Neeraj Narula,Christian Turbide,Deborah A Marshall,Karen L Madsen
INTRODUCTION Fecal microbial transplantation (FMT) has shown promise at inducing remission in ulcerative colitis. This study is the first of its kind to evaluate the efficacy and safety of FMT at inducing remission in Crohn's disease (CD). METHODS This double-blind, placebo-controlled trial was conducted in three Canadian academic centers; randomized patients with mild to moderate CD received FMT or
-
Albumin for Spontaneous Bacterial Peritonitis: Care Variation, Disparities and Outcomes. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-11-12 Marina Serper,Marya E Pulaski,Siqi Zhang,Tamar H Taddei,David E Kaplan,Nadim Mahmud
BACKGROUND Intravenous albumin reduces mortality in SBP. We sought to characterize albumin use for SBP over time and investigate patient and hospital-level factors associated with use. METHODS A retrospective cohort study in the Veterans Health Administration between 2008 and 2021 evaluated trends and patient, practice-, and facility-level factors associated with use among patients with cirrhosis hospitalized
-
Disparities, Trends, and Predictions to 2040 in Gastrointestinal Cancer Incidence, Mortality in the USA. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-11-12 Ying Huang,Hongbo Huang,Tingting Wei,Aijie Zhang,Heng Zhang,Ze Zhang,Yijing Xu,Ruiyao Wang,Ningyi Wan,Xiaohan Li,Jiaying Li,Yunhai Li,Fan Li
BACKGROUND and Importance: Growing gastrointestinal cancers in the U.S. necessitate further research due to substantial healthcare and economic impacts. This study aims to analyze trends and future projections for five major gastrointestinal cancers (colorectal, pancreatic, liver, stomach, and esophageal). METHODS Data were sourced from the Surveillance, Epidemiology, and End Results database, National
-
Optical Diagnosis in the Era or Artificial Intelligence. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-11-11 Roupen Djinbachian,Douglas K Rex,Daniel von Renteln
The development of new image enhancement modalities and improved endoscopic imaging quality have not led to increased adoption of resect-and-discard in routine practice. Studies have shown that endoscopists have the capacity to achieve quality thresholds to perform optical diagnosis, however, this has not led to acceptance of optical diagnosis as a replacement for pathology for diminutive (1-5mm) polyps
-
Response to Wei-Zhen Tang et al. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-11-11 Gabriele Dragoni,Tommaso Innocenti,Flavio Caprioli
-
The Underlying Causes of Secondary Bile Acid Diarrhea May Confound Cancer Risk. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-11-11 Christian Borup,Nynne Nyboe Andersen,Signe Wildt,Aske Thorn Iversen,Gry Juul Poulsen,Tine Jess,Lars Kristian Munck
-
The Minimally Invasive 1-Hr Esophageal String Test (EST) Monitors Therapeutic Changes in Mucosal Inflammation in Eosinophilic Esophagitis. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-11-06 Steven J Ackerman,Amir F Kagalwalla,Zhaoxing Pan,Joshua Wechsler,Kaitlin Keeley,Nirmala Gonsalves,Ikuo Hirano,Angelika Zalewski,Paul Menard-Katcher,Calies Menard-Katcher,Sandeep K Gupta,Nikhil Chauhan,Milica Grozdanovic,Dan Atkins,Nathalie Nguyen,Glenn T Furuta
BACKGROUND Endoscopy, standard-of-care for monitoring Eosinophilic Esophagitis (EoE), assesses mucosal inflammation. The Esophageal String Test (EST®), a minimally invasive swallowed capsule and immunoassays, quantifies EoE inflammation. We determined whether the EST/EoEScore can monitor disease in patients undergoing treatment. METHODS Thirty-three samples from 14 EoE patients (7 children, 7 adults)
-
Perforation of sigmoid colon by trans-anal decompression tube successfully treated using Over-The-Scope Clip system. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-11-06 Hideaki Kazumori,Kousuke Fukuda
-
Developing the ACG Leadership Pipeline: Impact of the ACG Institute Leadership Programs 2018-2023. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-11-05 Neena S Abraham,Meridith Phillips
-
Guidelines in Practice: Management of Acute Pancreatitis. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-11-05 Daniel Marino,Jasmine Saini,Scott Tenner
-
Duodenal Obstruction Caused by an Isolated Spontaneous Celiac Artery Dissection. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-11-04 Avi Toiv,Zachary Saleh,Andrew M Watson,Cyrus R Piraka
-
Using phosphatidylethanol as an adjunct to self-reported alcohol use improves identification of liver fibrosis risk. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-31 Pamela M Murnane,Majid Afshar,Gabriel Chamie,Robert L Cook,Tekeda Ferguson,Lamia Y Haque,Karen R Jacobson,Amy C Justice,Theresa W Kim,Mandana Khalili,Evgeny Krupitsky,Kathleen A McGinnis,Patricia Molina,Winnie R Muyindike,Bronwyn Myers,Veronica L Richards,Kaku So-Armah,Scott Stewart,Mark S Sulkowski,Phyllis C Tien,Judith A Hahn
INTRODUCTION Accurate assessment of alcohol use informs prevention and management of liver disease. We examined whether phosphatidylethanol (PEth, an alcohol metabolite) blood concentrations are associated with liver fibrosis risk independently of self-reported alcohol use, among persons with and without HIV. METHODS We pooled individual-level data from 12 studies from the United States, Russia, Uganda
-
From Blockage to Passage: Twin Gallstones' Journey Through the Gut. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-31 Cong Ning,Xuan Wang,Wenjing Liu
-
When and What to Test for Diarrhea: Focus on Stool Testing. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-31 Michael Camilleri
AIM To review stool diagnostic tests in acute and chronic diarrhea. METHOD Narrative review of published literature. RESULTS (A). In acute diarrhea, stool tests are indicated when there is strong pre-test probability of infectious etiology or C. difficile infection (CDI) suggested by >3 unformed bowel movements per 24h, symptoms lasting >7 days, and circumstances that are suggestive of infection. Several
-
Laryngeal Recalibration Therapy in Clinical Practice for Laryngopharyngeal Symptoms. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-31 Rena Yadlapati,Erin Walsh,Tiffany Taft
-
A Rare Culprit of Massive Gastrointestinal Bleeding: Amoeba. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-31 Zi-Ru Zhou,Jing Sun,Qunyan Zhou,Xia Li,Xinnong Zou,Qiang Zhan
-
Is ChatGPT a reliable tool in Autoimmune Hepatitis? Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-31 Francesca Colapietro,Daniele Piovani,Nicola Pugliese,Alessio Aghemo,Vincenzo Ronca,Ana Lleo
BACKGROUND AND AIMS Artificial intelligence-based chatbots offer a potential avenue for delivering personalized counselling to Autoimmune Hepatitis (AIH) patients. We assessed accuracy, completeness, comprehensiveness and safety of ChatGPT-4 responses to 12 inquiries out of a pool of 40 questions posed by four AIH patients. METHODS Questions were categorized into three areas: Diagnosis(1-3), Quality
-
Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Therapy Landscape. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-31 Sheena Bhushan,Aalam Sohal,Kris V Kowdley,Facg Faasld Agaf
Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) are rare, chronic cholestatic diseases that can progress to liver failure. The goals of treatment are to halt the progression of liver disease to cirrhosis and/or liver failure, and alleviate symptoms associated with these diseases. Ursodeoxycholic acid (UDCA) has historically been the first-line treatment for PBC, with obeticholic
-
Giant Meckel's Diverticulum Causing Pediatric Intestinal Obstruction. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-31 Ran Tang,Shi-Qin Qi,Cheng-Xiao Zhou
-
Ulcerative Jejunitis in Celiac Disease: A Thirty-Year U.S. Experience. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-30 Yevgen Chornenkyy,Masa Peric,David Marin Flores,Yuho Ono,Shweta A Shinagare,Katelyn Dannheim,Sarah Shannahan,Shana Rakowsky,Saja Asakrah,Monika Vyas,Jon Arnason,Daniel Leffler,Ciaran Kelly,Rupa Mukherjee,Amelie Therrien
INTRODUCTION Ulcerative jejunitis (UJ) or ulcerative enteritis (UE) is a rare complication of celiac disease (CeD). Guidelines regarding diagnosis and management are missing and these cases have seldom been reported in the United States. DESIGN Single center case-series of CeD in which UE developed at a large academic center in the USA. Clinical presentation, diagnosis, treatment, and evolution of
-
Cancer Risks in Attenuated and Classical Familial Adenomatous Polyposis: A Nationwide Cohort with Matched, Non-Exposed Individuals: Cancer and surgery in AFAP and FAP patients. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-30 Søren Hammershøj Beck,John Gásdal Karstensen,Steffen Bülow,Klaus Kaae Andersen,Thomas van Overeem Hansen,Helle Højen,Niels Jespersen,Tine Plato Kuhlmann,Hans Christian Pommergaard,Mads Damgaard Wewer,Laus Wullum,Anne Marie Jelsig,Johan Burisch
INTRODUCTION Familial adenomatous polyposis (FAP) is caused by pathogenic variants in the APC gene. FAP is usually categorized according to phenotype: classical FAP (CFAP) and attenuated FAP (AFAP); the latter is considered to have a milder disease course. We aimed to assess the risk of overall and specific cancers in CFAP and AFAP patients compared to matched, non-exposed individuals. METHODS All
-
Stool Impaction Preventing Obstetric Procedure: A Finding on MRI. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-30 Lauren S Eichenwald,Asra Saleem,Audrey H Calderwood
-
TM6SF2-rs58542926 genotype has opposing effects on incidence of hepatic and cardiac events in a community cohort: TM6SF2 effects on liver and cardiac outcomes. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-30 Vincent L Chen,Antonino Oliveri,Chinmay Raut,Yanhua Chen,Kelly C Cushing-Damm,Elizabeth K Speliotes
BACKGROUND AND AIMS TM6SF2-rs58542926-T is associated with increased cirrhosis and modestly decreased coronary artery disease prevalence. However, relative effects of TM6SF2 genotype on major adverse cardiovascular events (MACE) vs. liver-related events (LRE) is not known. APPROACH We utilized the UK Biobank, a prospective cohort with genetic and inpatient diagnosis data. The primary predictor was
-
Comparing Right-sided Colon Adenoma and Serrated Polyp Miss Rates with Water Exchange and CO2 Insufflation: A Randomized Controlled Trial. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-30 Chi-Liang Cheng,Jui-Hsiang Tang,Yu-Hsi Hsieh,Yen-Lin Kuo,Kuan-Chieh Fang,Chih-Wei Tseng,I-Chia Su,Chun-Chao Chang,Yi-Ning Tsui,Bai-Ping Lee,Ke-Yun Zou,Yun-Shien Lee,Felix W Leung
INTRODUCTION Postcolonoscopy colorectal cancers primarily occur in the right-sided colon because of missed adenomas and serrated polyps (SPs). Water exchange (WE) improves cleanliness and visibility of the right-sided colon. We hypothesized that WE could reduce the right-sided colon adenoma (rAMR) and SP miss rate (rSPMR) compared to standard colonoscopy. METHODS We randomly assigned 386 colonoscopy
-
Social Disadvantage and Disparities in Chronic Liver Disease: A Systematic Review. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-30 Bima J Hasjim,Alexandra Harris,Salva N Balbale,Joy E Obayemi,Molly Beestrum,Praneet Polineni,Mitchell Paukner,Mohsen Mohammadi,Oriana C Dentici,Kiarri N Kershaw,Marquita W Lewis-Thames,Sanjay Mehrotra,Daniela P Ladner
INTRODUCTION Social determinants of health (SDOH) may impact chronic liver disease (CLD) outcomes but are not clearly understood. We conducted a systematic review to describe the associations of SDOH with mortality, hospitalizations, and readmissions among patients with CLD. METHODS This review was registered (PROSPERO ID: CRD42022346654) and identified articles through MEDLINE, Embase, Cochrane Library
-
Circumferential En Bloc Esophageal Mucosal Sloughing and Esophageal Cast. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-25 Hamid Ullah,Shou-Jiang Tang
-
Hepatic steatosis estimated by VCTE-derived CAP scores was associated with lower risks of liver-related events and all-cause mortality in patients with chronic liver disease. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-25 Nicole J Kim,Philip Vutien,Joleen A Borgerding,Lauren A Beste,Muyi Li,Abbey Barnard-Giustini,Kay M Johnson,George N Ioannou
INTRODUCTION The Controlled Attenuated Parameter (CAP) score derived from vibration-controlled transient elastography (VCTE, i.e. Fibroscan®) is a well-validated marker of hepatic steatosis. It is unclear if CAP scores are associated with risks of liver-related outcomes or all-cause mortality. METHODS In this retrospective cohort study, we identified 7,587 U.S. Veterans (2,689 with cured hepatitis
-
Autoimmune Hepatitis and the Pathways and Targets for Therapies. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-25 Brian J Wentworth,Mary McGrath,Sahil Khanna,Craig Lammert
-
Psychological Distress is Prevalent and Interdependent Among Patients with Decompensated Cirrhosis and Their Caregivers. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-25 Nneka N Ufere,Chengbo Zeng,John Donlan,Daniel Shalev,Alyson Kaplan,Alan Noll,Annie Liu,Kedie Pintro,Nora Horick,Teresa Indriolo,Lucinda Li,Enya Zhu,Malia E Armstrong,Nancy Mason,Kirsten G Engel,Michaela Rowland,Karen O'Brien,Sara Kenimer,Michelle S Diop,Vicki Jackson,Jennifer C Lai,Raymond T Chung,Jamie M Jacobs,Maria Edelen,Areej El-Jawahri
OBJECTIVES Little is known about the interdependence of psychological distress among patients with decompensated cirrhosis (DC) and their caregivers. METHODS In this cross-sectional study we examined the interdependence of psychological distress (Hospital Anxiety and Depression Scale) among 127 patient-caregiver dyads using Actor-Partner Interdependence Modeling. RESULTS Among dyads, 26% had both partners
-
Inclusion of a Society-Endorsed Practice Guideline in Computed Tomography Reports Improves Post-Diverticulitis Colonoscopy Adherence. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-25 Luke T Chmielecki,Nathan Pham,Marisa Wu,Avneesh Gupta,Laura Chu,Paul C Schroy
-
Raising the Bar: Is Hepatocellular Carcinoma Surveillance Warranted for Patients With Alcohol-Associated Cirrhosis? Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-24 Andrew M Moon
-
Nonmalignant dermatologic disorders in Inflammatory Bowel Disease. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-23 Kim L Isaacs,Christopher J Sayed
Inflammatory bowel disease (IBD) is associated with extraintestinal manifestations (EIMs) that can affect multiple body systems. EIMs are seen in up to 50 % of patients with IBD. [1] Skin involvement is particularly common occurring in up to 15-20% of patients. [1] Skin reactivity presents in multiple forms with unique pathology. Therapy for IBD also may affect the skin directly though inflammatory
-
Guidelines in Practice: Focal Liver Lesions. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-21 Rahul Sandella,Yael Wollstein,Anjana Pillai
-
Incidence of thiopurine induced severe myelosuppression in a nationwide cohort of inflammatory bowel disease patients. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-18 Nabeel Khan,Dhruvan Patel,Ramaswamy Sundararajan
INTRODUCTION There is paucity of data on the incidence of severe thiopurine (TP)-induced myelosuppression (TIM) among inflammatory bowel disease (IBD) patients. METHODS Utilizing the Veterans Affairs Healthcare system we identified IBD patients with normal pre-treatment thiopurine S-methyltransferase(TPMT) levels who received TPs for 6 months and developed severe TIM. RESULTS Among 73,392 IBD patients
-
HLA DQA1*05 and risk of anti-TNF treatment failure and anti-drug antibody development in children with Crohn's Disease: HLA DQA1*05 and Pediatric Crohn's Disease. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-18 Jeremy Adler,Joseph A Galanko,Rana Ammoury,Keith J Benkov,Athos Bousvaros,Brendan Boyle,José M Cabrera,Kelly Y Chun,Jill Dorsey,Dawn R Ebach,Ann M Firestine,Ajay S Gulati,Hans H Herfarth,Traci W Jester,Jess L Kaplan,Ian Leibowitz,Tiffany M Linville,Peter A Margolis,Phillip Minar,Zarela Molle-Rios,Jonathan Moses,Kelly Olano,Dinesh S Pashankar,Lisa Pitch,Shehzad A Saeed,Charles M Samson,Kelly Sandberg
OBJECTIVES HLA DQA1*05 has been associated with the development of anti-drug antibodies (ADA) to tumor necrosis factor antagonists (anti-TNF) and treatment failure among adults with Crohn's disease (CD). However, findings from other studies have been inconsistent with limited pediatric data. METHODS We analyzed banked serum from patients with CD < 21 years of age enrolled in COMBINE, a multi-center
-
Four-Dimensional Impedance Manometry in Esophageal Motility Disorders. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-18 Eric Goudie,Wenjun Kou,John E Pandolfino,Isis K Araujo,Panyavee Pitisuttithum,Sourav Halder,Peter J Kahrilas,Dustin A Carlson
INTRODUCTION Four-dimensional high-resolution impedance manometry (4D HRM) uses impedance to estimate esophageal luminal cross-sectional area and track nadir impedance to measure intrabolus pressure (IBP). We aimed to determine whether 4D HRM metrics could define abnormal esophagogastric junction (EGJ) opening between Chicago Classification version 4.0 motility disorders and compare 4D HRM with functional
-
Transverse Colon Penetration by Migrated Intrauterine Device: A Rare Complication. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-18 Tae-Gyun Lee,Jin-Min Jung,Sun Jung Kim,Chang Woo Kim
-
Refinement of Hy's Law using the Drug-Induced Liver Injury Network Database. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-18 A Sidney Barritt,Paul H Hayashi,Andrew A Stolz,Huiman Barnhart,Jay H Hoofnagle,
BACKGROUND Hyman Zimmerman observed that hepatocellular (HC) drug-induced liver injury (DILI) with jaundice had a mortality rate of ≥10% (Hy's Law). Hy's Law does not specify the timing of liver tests nor the definition of HC DILI versus cholestatic or mixed (C/M) DILI. We aimed to assess the validity of Hy's Law in the prospective Drug-Induced Liver Injury Network (DILIN) cohort. METHODS Drugs with
-
Treatment preference archetypes in eosinophilic esophagitis and their implications for therapy. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-18 Joy W Chang,Kelcie Brophy,Kerry A Ryan,Joel H Rubenstein,Evan S Dellon,Lauren P Wallner,Hyungjin Myra Kim,Raymond De Vries
BACKGROUND Little is known about how patients make decisions about and prioritize, therapies and disease management in eosinophilic esophagitis (EoE). We aimed to systematically identify and characterize patient perspectives and attitudes that influence decision making for EoE management. METHODS To understand the diverse attitudes and values of EoE patients, we designed a study using the Q-method
-
Expanding Insights on Ambulatory Reflux Monitoring: Future Directions and Clinical Integration. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-18 Francesco Calabrese,Andrea Pasta,Edoardo Vincenzo Savarino,Vincenzo Savarino,Edoardo Giovanni Giannini,Elisa Marabotto
-
Solitary Colonic Ganglioneuroma With Central Depression: A Rare Case With Unique Morphology. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-18 Masachika Saino,Toshio Kuwai,Shiro Oka
-
Improving the Diagnostic Accuracy of RECAM in North American Patients with Suspected Idiosyncratic Drug-Induced Liver Injury: Improving RECAM accuracy. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-18 Jacob Ciricillo,Adam Myer,Amoah Yeboah-Korang,Askanda Osman,Farrah Rahim,David G Goldfarb,Yeshika Sharma,Jeremy Louissaint,Kenneth E Sherman,Robert J Fontana
BACKGROUND The RECAM is an updated, electronic version of the RUCAM to diagnose DILI. The primary aim of this study was to compare RECAM versus RUCAM in patients with suspected DILI. METHODS Patient encounters from 10/1/2015 to 9/30/2019 were searched for suspected DILI using ICD-10 K71 codes for toxic liver disease. DILIN expert opinion scores were assigned to each case (1/2/3= probable DILI, 4/5=
-
Disproportionately Increasing Incidence of Inflammatory Bowel Disease in Females and the Elderly: An Update Analysis from the Global Burden of Disease Study 2021. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-18 Pojsakorn Danpanichkul,Kwanjit Duangsonk,Agnes Hy Ho,Passisd Laoveeravat,Chawinthorn Vuthithammee,Disatorn Dejvajara,Vitchapong Prasitsumrit,Thanida Auttapracha,Busara Songtanin,Panu Wetwittayakhlang,Rashid N Lui,Gursimran Singh Kochhar,Siew C Ng,Francis A Farraye,Karn Wijarnpreecha
OBJECTIVE To update the global burden of Inflammatory Bowel Disease (IBD) using data from the Global Burden of Disease (GBD) 2021. METHODS Data from GBD 2021 were analyzed to assess the IBD burden. RESULTS In 2021, there were 375,140 new cases and 3.83 million total cases of IBD. Elderly-onset IBD accounted for 11% of incidences. 167 countries increased IBD incidence rate, with rates rising in females
-
The role of P-CABs in GERD. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-17 Colin W Howden
Potassium-competitive acid blockers (P-CABs) constitute a relatively new class of gastric acid-suppressing drugs. Among this class, vonoprazan is the first to have been approved in the United States. However, some P-CABs including vonoprazan, tegoprazan and fexuprazan have been available in other countries since at least 2014. The first aim of this article is to review pharmacological differences between
-
Should We Rest on a Rest? A Well-Differentiated Neuroendocrine Tumor Arising From Pancreatic Heterotopia. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-17 Donna E Leet,Kwun Wah Wen,Abdul Kouanda
-
Gastrointestinal Xanthomas and Ichthyosis: A Mild Phenotype of CHILD Syndrome (NSDHL Gene Mutation). Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-17 Do Han Kim,Michael Marble,Juan E Corral
-
Medical Therapies for Prevention and Treatment of Inflammatory Pouch Disorders-A Systematic Review and Meta-Analysis. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-16 Gaurav Syal,Edward Barnes,Laura Raffals,Elie Al Kazzi,John Haydek,Manasi Agarwal,Siddharth Singh
INTRODUCTION Pouchitis and Crohn's-like disease of the pouch (CLDP) are common in patients who undergo ileal pouch anal anastomosis for ulcerative colitis. We conducted separate systematic reviews to evaluate the effectiveness of available interventions to prevent and treat pouchitis and CLDP. METHODS Through systematic literature reviews, we identified studies that evaluated the effectiveness of probiotics
-
Bile entangled: an unexpected cause of biliary stricture. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-16 Sofia Bizarro Ponte,Andreia Rei,Sandra Correia,Paulo Salgueiro
-
Enhancing Intrapancreatic Fat Deposition and Pancreatitis Research With Additional Considerations. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-14 Qing Zhou
-
Enhancing the Management of Alcohol-Related Liver Disease: Addressing Socioeconomic Disparities and the Role of Social Work in Intervention Strategies. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-14 Zhangbing Zhou,Liu Wang,Yunfeng Chen
-
Development and Validation of a Pediatric Celiac Disease-Specific Quality of Life Measure. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-14 Shayna Coburn,Paige J Trojanowski,Jack Vagadori,Pamela Hinds,Monique Germone,Edwin Liu,Randi Streisand,James Bost
INTRODUCTION Quality of life (QOL) is critical in screening and management of chronic medical conditions, including celiac disease (CD). This project aimed to develop a CD-specific pediatric QOL measure ("CDLIFE") with parallel self- and parent-report forms by generating items through concept elicitation interviews, iterative refinement using cognitive debriefing interviews, and evaluating its psychometric
-
Spleen Stiffness to Predict Varices Needing Treatments: Appropriate Patient Selection is the Key to Success. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-14 Harsh Prakash Jain,Shivam Sethi
-
Resurgent Inflation and its Impact on Medicare Reimbursements for Outpatient Gastroenterology Procedures. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-11 Dipen D Patel,Stephen T Amann,Benjamin Hart
INTRODUCTION Rising healthcare costs have led to decreasing reimbursements for various procedures and providers. We chose to analyze Medicare reimbursement trends for 26 esophagogastroduodenoscopy (EGD) and 31 colonoscopy current procedural terminology (CPT) codes from 2018 to 2023 for hospital outpatient centers, ambulatory surgical centers and gastroenterologists. We also wanted to look at the effects
-
Focusing on the Key Factors in the Treatment of Pediatric Crohn's Disease: A Re-Examination of the Relationship Between Body Mass Index and Antitumor Necrosis Factor Treatment Response. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-10 Jie Chen,Changlin Zhai,Haihua Pan
-
Family History of Colorectal Cancer and the Risk of Colorectal Neoplasia: A Systematic Review and Meta-Analysis. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-09 Kai Gao,Huyi Jin,Yi Yang,Jiayu Li,Yuanliang He,Ruiyao Zhou,Wanting Zhang,Xiangrong Gao,Zongming Yang,Mengling Tang,Jianbing Wang,Ding Ye,Kun Chen,Mingjuan Jin
INTRODUCTION Although there is enough pooled evidence supporting the positive association between family history of colorectal cancer (CRC) in first-degree relatives (FDRs) and the risk of CRC, synthesized data on its association with the risk of other colorectal neoplasia are lacking. Therefore, we aimed to systematically assess this issue. METHODS We searched PubMed, Web of Science, and Embase from
-
Effect of Adopting a Gluten-Free Diet on Exposure to Arsenic and Other Heavy Metals in Children With Celiac Disease: A Prospective Cohort Study. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-09 Nan Du,Denis Chang,Jason Boisvert,Bridget Hron,Rachel Rosen,Tracy Punshon,Jocelyn Silvester
INTRODUCTION Lifelong adherence to a gluten-free diet (GFD) is the primary treatment of celiac disease (CeD), a gluten-driven enteropathy. Concerns have been raised about increased exposure to arsenic from a GFD because rice, which naturally bioaccumulates arsenic, is commonly used as a substitute for gluten-containing grains such as wheat. We hypothesize that arsenic exposure increases in newly diagnosed
-
Complete Stenosis After Endoscopic Submucosal Dissection of a Large Circumferential Rectal Lesion. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-09 Yoshihiro Kishida,Henrik Thorlacius
-
Predicting and Preventing Bleeding in Patients With Cirrhosis Undergoing Procedures. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-09 Jason Michael Erno,Erica Villa,Nicolas Michael Intagliata
-
Expected 8-Week Prenatal vs 12-Week Perinatal Tenofovir Alafenamide Prophylaxis to Prevent Mother-to-Child Transmission of Hepatitis B Virus: A Multicenter, Prospective, Open-Label, Randomized Controlled Trial. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-09 Qing-Lei Zeng,Yi-Hua Zhou,Xiao-Ping Dong,Ji-Yuan Zhang,Guang-Ming Li,Jiang-Hai Xu,Zhi-Min Chen,Ning Song,Hong-Xu Zhang,Ru-Yue Chen,Xue-Yan Lv,Shuo Huang,Wei-Zhe Li,Ya-Jie Pan,Ying-Hua Feng,Zhi-Qin Li,Guo-Fan Zhang,Wan-Bao Lin,Guo-Qiang Zhang,Guo-Tao Li,Wei Li,Yan-Li Zeng,Da-Wei Zhang,Guang-Lin Cui,Jun Lv,Yan-Min Liu,Hong-Xia Liang,Chang-Yu Sun,Fu-Sheng Wang,Zu-Jiang Yu
INTRODUCTION The course of maternal antiviral prophylaxis to prevent mother-to-child transmission of hepatitis B virus (HBV-MTCT) varies greatly, and it has not been demonstrated in a randomized controlled study. METHODS In this multicenter, open-label, randomized controlled trial, eligible pregnant women with HBV DNA of 5.3-9.0 log 10 IU/mL who received tenofovir alafenamide fumarate (TAF) from the
-
Hydrochloric Acid Enema-Induced Corrosive Proctocolitis. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-10-09 Yinghao Sun,Qipu Wang,Qiang Wang,Hong Yang